Investors & News

About Vivoryon

Vivoryon Therapeutics is a precision intervention company focused on discovering and developing first-in-class therapies for patients suffering from for age-related diseases.

We have built a pipeline of product candidates across various stages of development, currently focused on Alzheimer’s disease and cancer immune checkpoint inhibition.

Events

January 2020

12 – 16: J.P. Morgan Healthcare Conference, San Francisco, USA